Work

A phase II study to evaluate the pharmacokinetics, safety, and tolerability of Risperidone ISM multiple intramuscular injections once every 4 weeks in patients with schizophrenia

Year: 2017

Type: article

Source: International Clinical Psychopharmacology

DOI: 10.1097/yic.0000000000000203

Authors: Lourdes A. Carabias, Jordi Llaudó, Ignacio Ayani, Javier Martínez, Robert E. Litman, Ibón Gutierro

Institution: Laboratorios Farmaceúticos Rovi (Spain)

Language: English

Topic: Schizophrenia research and treatment

Subfield: Psychiatry and Mental health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Agencia de Innovación y Desarrollo de Andalucía, U.S. National Library of Medicine

OpenAlex ID: W2767770516

FWCI: 0.617

Cites: 24

Cited by: 24

Related to: 10